IKZF3 and B-cell chronic lymphocytic leukemia: In more mature B cell malignancies, such as CLL, expression of IKZF3 is upregulated, and high levels of IKZF3 correlate with inferior clinical outcome [101], indicating an oncogenic function of the Ikaros family.